Veterinary Medicines

Karprovet 50 mg tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Karprovet 50 mg tablets for dogs
Rycarfa Flavour 50 mg, tabletės šunims
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Blister (OPA/Al/PVC-Al): 500 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 100 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 50 tablets (10 tablets/blister) in a box.
  • Blister (OPA/Al/PVC-Al): 20 tablets (10 tablets/blister) in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • Krka-Farma d.o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/10/1947/001-004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0239/003
Concerned member states:
  • Belgium
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 27/10/2024
Download

RV1947.pdf

Lithuanian (PDF)
Published on: 28/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."